Content about Ranitidine

September 20, 2012
P&G punches up Prilosec OTC offering with wildberry flavoring

Procter & Gamble this week will begin shipping a wildberry-flavored Prilosec OTC.

NEW YORK — Procter & Gamble this week will begin shipping a wildberry-flavored Prilosec OTC.

The proton-pump inhibitor will not come in a chewable form, however, and will feature the message "Swallow — Do Not Chew" prominently on its packaging.

December 22, 2011
Covis acquires U.S. rights to five GSK drugs

A Swiss drug maker is acquiring the U.S. rights for several GlaxoSmithKline drugs.

ZUG, Switzerland — A Swiss drug maker is acquiring the U.S. rights for several GlaxoSmithKline drugs.

Covis Pharma Sarl announced Thursday that it had acquired the rights to the antibiotic Fortaz (ceftazidime), the antibiotic Zinacef (cefuroxime), the heart arrhythmia drug Lanoxin (digoxin), the antidepressant Parnate (tranylcypromine sulfate) and the gastroesophogeal reflux disease drug Zantac (ranitidine hydrochloride). GSK will retain rights to the drugs outside the United States.

Financial terms of the deal were not disclosed.

May 17, 2011
Perrigo receives final approval for generic Zantac 150

Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

ALLEGAN, Mich. — Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

Zantac 150 has annual sales of approximately $110 million, as measured by SymphonyIRI Group, Perrigo reported.

March 22, 2011
Hi-Tech Pharmacal granted final approval for generic Zantac syrup

Hi-Tech Pharmacal was granted final approval from the Food and Drug Administration for its treatment of duodenal ulcers.

AMITYVILLE, N.Y. — Hi-Tech Pharmacal was granted final approval from the Food and Drug Administration for its treatment of duodenal ulcers.

The drug maker said its abbreviated new drug application for ranitidine syrup in the 15-mg/mL strength was approved. Ranitidine syrup is a generic version of GlaxoSmithKline’s Zantac syrup, which garnered sales of $21 million for 12 months ended in December 2010, according to IMS sales data.

Hi-Tech currently has 13 products awaiting approval at the FDA, the company said.

December 7, 2010
P&G, GSK hold their own 
in crowded antacid aisle

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


June 6, 2010
Marketing pieces of the digestive puzzle

When Schering-Plough Consumer Healthcare began distributing its Zegerid OTC in April, the last piece of...

July 31, 2007
ECRM Over the Counter & Personal and Beauty Care 2007

The ECRM OTC & PBC report covers trends in bath and body, facial skin care, oral care, baby care, men's grooming, ethnic hair care, analgesics, digestives, allergy and health care, including product previews of Zantac mint tablets, Arnicare Gel, Airplus Ultra Arch, Traumeel and Murine Earigate.

The ECRM OTC & PBC report covers trends in bath and body, facial skin care, oral care, baby care, men's grooming, ethnic hair care, analgesics, digestives, allergy and health care, including product previews of Zantac mint tablets, Arnicare Gel, Airplus Ultra Arch, Traumeel and Murine Earigate. Click below to download the PDF of ECRM Over the Counter & Personal Beauty Care 2007.